Showing results (21-30 of 502) with videos related to
Sort By:
Pageof 51
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|August 12, 2011
Targeting bone as a therapy for myelomaPing Wu, Gareth J MorganLeukemia|February 23, 2018
Loss of heterozygosity as a marker of homologous repair deficiency in multiple myeloma: a role for PARP inhibition?Charlotte Pawlyn, Andrea Loehr, Cody Ashby, et al.Blood|May 18, 2006
Integration of global SNP-based mapping and expression arrays reveals key regions, mechanisms, and genes important in the pathogenesis of multiple myelomaBrian A Walker, Paola E Leone, Matthew W Jenner, et al.Blood|October 15, 2010
Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myelomaBrian A Walker, Christopher P Wardell, Laura Chiecchio, et al.Oncotarget|June 10, 2015
Integrated analysis of microRNAs, transcription factors and target genes expression discloses a specific molecular architecture of hyperdiploid multiple myelomaMaria Teresa Di Martino, Pietro Hiram Guzzi, Daniele Caracciolo, et al.Journal of Molecular Biology|August 30, 2016
The Kinetic Stability of a Full-Length Antibody Light Chain Dimer Determines whether Endoproteolysis Can Release Amyloidogenic Variable DomainsGareth J Morgan, Jeffery W KellyHematology/Oncology Clinics of North America|October 25, 2020
The Process of Amyloid Formation due to Monoclonal ImmunoglobulinsGareth J Morgan, Jonathan S WallHematology. American Society of Hematology. Education Program|December 13, 2012
What is the evidence for the use of bisphosphonate therapy in newly diagnosed multiple myeloma patients lacking bone disease?Frederick L Locke, Gareth J MorganCritical Reviews in Oncology/Hematology|July 6, 2013
Role of thalidomide in the treatment of patients with multiple myelomaGareth J Morgan, Faith E DaviesInterventional Cardiology Clinics|November 20, 2018
Pulmonary Artery StentingJenny E Zablah, Gareth J MorganPageof 51